Cargando…

Radiomics and deep learning models to differentiate lung adenosquamous carcinoma: A multicenter trial

Adenosquamous carcinoma (ASC) is frequently misdiagnosed or overlooked in clinical practice due to its dual histological components and potential transformation from either adenocarcinoma (ADC) or squamous cell carcinoma (SCC). Our study aimed to differentiate ASC from ADC and SCC by incorporating f...

Descripción completa

Detalles Bibliográficos
Autores principales: Chu, Xianjing, Niu, Lishui, Yang, Xianghui, He, Shiqi, Li, Aixin, Chen, Liu, Liang, Zhan, Jing, Di, Zhou, Rongrong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10474462/
https://www.ncbi.nlm.nih.gov/pubmed/37664612
http://dx.doi.org/10.1016/j.isci.2023.107634
_version_ 1785100499954958336
author Chu, Xianjing
Niu, Lishui
Yang, Xianghui
He, Shiqi
Li, Aixin
Chen, Liu
Liang, Zhan
Jing, Di
Zhou, Rongrong
author_facet Chu, Xianjing
Niu, Lishui
Yang, Xianghui
He, Shiqi
Li, Aixin
Chen, Liu
Liang, Zhan
Jing, Di
Zhou, Rongrong
author_sort Chu, Xianjing
collection PubMed
description Adenosquamous carcinoma (ASC) is frequently misdiagnosed or overlooked in clinical practice due to its dual histological components and potential transformation from either adenocarcinoma (ADC) or squamous cell carcinoma (SCC). Our study aimed to differentiate ASC from ADC and SCC by incorporating features of enhanced CTs and clinical characteristics to build radiomics and deep learning models. The classification models were trained in Xiangya Hospital and validated in two other independent hospitals. The areas under the receiver operating characteristic curves (AUC), accuracy, sensitivity, specificity, positive predictive value, and negative predictive value were used to estimate the performance. The optimal three-class classification model achieved a maximum AUC of 0.89 and accuracy of 0.81 in external validation sets, AUC of 0.99 and accuracy of 0.99 in the internal test set. These findings highlight the efficacy of our models in differentiating ASC, providing a non-invasive, timely, and accurate diagnostic approach before and during the treatment.
format Online
Article
Text
id pubmed-10474462
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-104744622023-09-03 Radiomics and deep learning models to differentiate lung adenosquamous carcinoma: A multicenter trial Chu, Xianjing Niu, Lishui Yang, Xianghui He, Shiqi Li, Aixin Chen, Liu Liang, Zhan Jing, Di Zhou, Rongrong iScience Article Adenosquamous carcinoma (ASC) is frequently misdiagnosed or overlooked in clinical practice due to its dual histological components and potential transformation from either adenocarcinoma (ADC) or squamous cell carcinoma (SCC). Our study aimed to differentiate ASC from ADC and SCC by incorporating features of enhanced CTs and clinical characteristics to build radiomics and deep learning models. The classification models were trained in Xiangya Hospital and validated in two other independent hospitals. The areas under the receiver operating characteristic curves (AUC), accuracy, sensitivity, specificity, positive predictive value, and negative predictive value were used to estimate the performance. The optimal three-class classification model achieved a maximum AUC of 0.89 and accuracy of 0.81 in external validation sets, AUC of 0.99 and accuracy of 0.99 in the internal test set. These findings highlight the efficacy of our models in differentiating ASC, providing a non-invasive, timely, and accurate diagnostic approach before and during the treatment. Elsevier 2023-08-16 /pmc/articles/PMC10474462/ /pubmed/37664612 http://dx.doi.org/10.1016/j.isci.2023.107634 Text en © 2023 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Article
Chu, Xianjing
Niu, Lishui
Yang, Xianghui
He, Shiqi
Li, Aixin
Chen, Liu
Liang, Zhan
Jing, Di
Zhou, Rongrong
Radiomics and deep learning models to differentiate lung adenosquamous carcinoma: A multicenter trial
title Radiomics and deep learning models to differentiate lung adenosquamous carcinoma: A multicenter trial
title_full Radiomics and deep learning models to differentiate lung adenosquamous carcinoma: A multicenter trial
title_fullStr Radiomics and deep learning models to differentiate lung adenosquamous carcinoma: A multicenter trial
title_full_unstemmed Radiomics and deep learning models to differentiate lung adenosquamous carcinoma: A multicenter trial
title_short Radiomics and deep learning models to differentiate lung adenosquamous carcinoma: A multicenter trial
title_sort radiomics and deep learning models to differentiate lung adenosquamous carcinoma: a multicenter trial
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10474462/
https://www.ncbi.nlm.nih.gov/pubmed/37664612
http://dx.doi.org/10.1016/j.isci.2023.107634
work_keys_str_mv AT chuxianjing radiomicsanddeeplearningmodelstodifferentiatelungadenosquamouscarcinomaamulticentertrial
AT niulishui radiomicsanddeeplearningmodelstodifferentiatelungadenosquamouscarcinomaamulticentertrial
AT yangxianghui radiomicsanddeeplearningmodelstodifferentiatelungadenosquamouscarcinomaamulticentertrial
AT heshiqi radiomicsanddeeplearningmodelstodifferentiatelungadenosquamouscarcinomaamulticentertrial
AT liaixin radiomicsanddeeplearningmodelstodifferentiatelungadenosquamouscarcinomaamulticentertrial
AT chenliu radiomicsanddeeplearningmodelstodifferentiatelungadenosquamouscarcinomaamulticentertrial
AT liangzhan radiomicsanddeeplearningmodelstodifferentiatelungadenosquamouscarcinomaamulticentertrial
AT jingdi radiomicsanddeeplearningmodelstodifferentiatelungadenosquamouscarcinomaamulticentertrial
AT zhourongrong radiomicsanddeeplearningmodelstodifferentiatelungadenosquamouscarcinomaamulticentertrial